Role of non-esterified fatty acids in the pathogenesis of Type 2 diabetes mellitus

Diabetic Medicine

Volumn 15, Issue 5, 1998, Pages 360-366

  Paolisso, G ^a,c   Howard, B V ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Medlantic Research Institute   (United States)

^c Servizio di Astanteria Medica   (Italy)

Author keywords

Glucose intolerance; Non esterified fatty acids; Type 2 diabetes mellitus

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN;

FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; GLUCOSE UTILIZATION; HUMAN; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; REVIEW;

EID: 0031957844     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199805)15:5<360::AID-DIA568>3.0.CO;2-W     Document Type: Review

References (51)

1. Randle PJ, Hales CN, Garland PB, Newsholme EA. The glucose/fatty acid cycle. Its role in insulin insensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963; I: 785-789.
2. Ashour U, Honsford RG. Effect of free acids and ketones on the activity of pyruvate dehydrogenase in skeletal muscle mithocondria. Biochem J 1983; 214: 725-736.
3. Lillioja S, Bogardus C, Mott D, Kennedy LA, Knowler WC, Howard BV. Relationship between insulin-mediated glucose disposal and lipid metabolism in man. J Clin Invest 1985; 75: 1106-1115.
4. Bonadonna RC, Zych K, Boni C, Ferrannini E, De Fronzo RA. Time dependence of the interaction between glucose and lipid in humans. Am J Physiol 1989; 257: E49-E56.
5. Balasse EO, Neef MA. Influence of nicotinic acid on the rates of turnover and oxidation of plasma glucose in man. Metabolism 1973; 22: 1193-1204.
6. Felber JP, Haesler E, Jequier E. Metabolic origin of insulin resistance in obesity with and without type 2 (non-insulin dependent) diabetes mellitus. Diabetologia 1993; 36: 1221-1229.
7. Paolisso C, Tataranni PA, Foley JE, Bogardus C, Howard BV, Ravussin E. A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM. Diabetologia 1995; 38: 1213-1217.
8. Charles MA, Eschwege E, Thibult N, Claude JR, Warnet JM, Rosselin GE, et al. The role of free fatty acids in the deterioration of glucose tolerance in Caucasian subjects. Results of the Paris Prospective Study. Diabetologia 1997; 40: 1101-1106.
9. Prentki M, Corkey BE. Are the β-cell signalling molecules malonyl-CoA and cytosolic long-chain Acyl-CoA implicated in multiple tissue defects of obesity and NIDDM. Diabetes 1996; 45: 273-283.
10. Sclafani A. Dietary obesity models: In: Bjontorp P, Brodoff EE, eds. Obesity. Philadelphia: Lippincott, 1992: 241-248.
11. Bennett PH. Epidemiology of diabetes mellitus. In: Rifkin H, Porte D Jr, eds. Ellenberg and Rifkin's Diabetes Mellitus: Theory and Practice. New York: Elsevier, 1990: 357-377.
12. Porte D. β-cells in type II diabetes mellitus. Diabetes 1991; 40: 166-180.
13. Unger RH. Lipotoxicity in the pathogenesis of obesity dependent NIDDM. Genetic and clinical implications. Diabetes 1995; 44: 863-870.
14. Hotamisligil GS, Spiegelman BM. Tumor necrosis factor-α: a key component of the obesity diabetes link. Diabetes 1994; 43: 1271-1278.
15. Chen L, Alam T, Johnson JH, Hughes S, Orci L, Unger RH. Regulation of β-cell glucose transporter gene expression. Proc Natl Acad Sci 1990; 87: 4088-4092.
16. Elks ML. Chronic perifusion of rat islets with palmitate suppresses glucose-stimulated insulin release. Endocrinology 1990; 133: 1580-1589.
17. Capito K, Hansen SE, Hedeskov CJ, Islin H, Thams P. Fat-induced changes in mouse pancreatic islet insulin secretion, insulin biosynthesis and glucose metabolism. Acta Diabetol 1992; 28: 193-198.
18. Weber G, Hird Convery HJ, Lea MA, Stamm NB. Feedback inhibition of key glycolytic enzymes in liver: action of free fatty acids. Science 1966; 154: 1357-1360.
19. Sako Y, Grill VE. A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and β-cell oxidation through a process likely coupled to fatty acid oxidation. Endocrinology 1993; 133: 208-214.
20. Zhou YP, Grill VE. Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J Clin Invest 1994; 93: 870-876.
21. Brun T, Assimacopoulos-Jeannet F, Corkey BE, Prentki M. Long-chain fatty acids inhibit acetyl-CoA carboxylase gene expression in the pancreatic β-cell line INS-1. Diabetes 1997; 46: 393-400.
22. Milburn JL, Hirose H, Lee YH, Nagasawa Y, Ogawa A, Ohneda M, et al. Pancreatic β-cells in obesity: evidence for induction of functional, morphological and metabolic abnormalities by increased long-chain fatty acids. J Biol Chem 1995; 270: 1295-1299.
23. Lehmann J, Moore LB, Smith-Oliver TA, Wilkinson WO, Willson TM, Kliewer SA. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator activated receptor gamma (PPARgamma). J Biol Chem 1995; 270: 12953-12956.
24. Castelein H, Gulick T, Declerq PE, Mannaerts GP, Moore DD, Baes MI. The peroxisome proliferator activated receptor regulates malic enzyme expression. J Biol Chem 1994; 269: 26754-26758.
25. Gulick T, Cresci S, Caira T, Moore DD, Kelly DP. The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidation enzyme gene expression. Proc Natl Acd Sci 1994; 91: 11012-11016.
26. Keller H and Wahli W. Peroxisome proliferator activated receptors: a link between endocrinology and nutrition. Trends Endocrinology Metab 1993; 4: 291-296.
27. Paolisso G, Gambardella A, Amato L, Tortoriello R, D'Amore A, Varricchio M, D'Onofrio F. Opposite effects of short-and long-term fatty acid infusion on insulin secretion in healthy subjects. Diabetologia 1995; 38: 1295-1299.
28. Boden G, Chen X, Rosner J, Barton M. Effects of 48 h fat insulin secretion and glucose utilization. Diabetes 1995; 44: 1239-1242.
29. Van Cauter E, Mestrez F, Sturius J, Polonski KS. Estimation of insulin secretion rate from C-peptide levels: comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 1992; 41: 368-377.
30. Paolisso G, Tagliamonte MR, Rizzo MR, Gualdiero P, Saccomanno F, Gambardella A, et al. Acipimox potentiates glucose induced insulin secretion in first degree relatives of individuals with type II diabetes. Submitted to J Am Med Assoc 1997.
31. Warram J, Martin B, Krolewski A, Soellener S, Kahn C. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med 1990; 113: 909-915.
32. Pimenta W, Korytkowski M, Kitrakou A, Jenssen T, Yki-Jarvinen H, Evron W, et al. Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose tolerant individuals with a first-degree NIDDM relatives. J Am Med Assoc 1995; 273: 1855-1861.
33. Shimabukuro M, Ohneda M, Lee Y, Unger RH. Role of nitric oxide in obesity-induced beta cell disease. J Clin Invest 1997; 100: 290-295.
34. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 1997; 46: 3-10.
35. Bevilacqua S, Buzzigoli G, Bonadonna R, Brandi S, Oleggini M, Boni C, et al. Operation of Randle's cycle in patients with NIDDM: Diabetes 1990; 39: 383-389.
36. Boden G, Chen K, Ruiz J, White JV, Rossetti L. Mechanisms of fatty acid induced inhibition of glucose uptake. J Clin Invest 1994; 93: 2438-2446.
37. Yki-Jarvinen H, Puhakainen HI, Saloranta C, Groop L, Taskinen MR. Demonstration of a novel feedback mechanism between FFA oxidation from intracellular and intravascular sources. Am J Physiol 1991; 260: E680-E689.
38. Saloranta C, Fransiila-Kallunki A, Ekstrand A, Taskinen MR, Groop L. Modulation of hepatic glucose production by non-esterified fatty acids in type 2 (non-insulin dependent) diabetes mellitus. Diabetologia 1991; 34: 409-115.
39. Boden G, Chen X. Effects of fat on glucose uptake and utilization in patients with non-insulin dependent diabetes mellitus. J Clin Invest 1995; 96: 1261-1268.
40. Gonzales-Manchin C, Ayuso MS, Parrilla R. Control of hepatic gluconeogenesis: role of fatty acids oxidation. Arch Biochem Biophys 1989; 271: 1-9.
41. Morand C, Remesy C, Demigne C. Fatty acids are potent modulators of lactate utilization in isolated hepatocytes from fed rats. Am J Physiol 1993; 264: E816-E823.
42. Rebrin K, Steil GM, Getty L, Bergman RN. Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes 1995; 44: 1038-1045.
43. Fulcher GR, Walker M, Catalano C, Aquis L, Alberti KGMM. Metabolic effects of suppression of nonesterified fatty acid levels with acipimox in obese NIDDM subjects. Diabetes 1442; 41: 1400-1408.
44. Worm O, Henriksen JE, Vaag A, Thye-Ronn P, Melander A, Beck-Nielsen H. Pronounced blood glucose-lowering effect of the antilipolytic drug acipimox in non-insulin-dependent diabetes mellitus patients during a 3-day intensified treatment period. J Clin Endocrinol Metab 1994; 78: 717-721.
45. Vaag A, Skott P, Damsbo P, Gall MA, Richter EA, Beck-Nielsen H. Effect of the antilipolytic nicotinic acid analogue acipimox on whole body and skeletal muscle glucose metabolism in patients with noninsulin dependent diabetes mellitus. J Clin Invest 1941; 88: 1202-1290.
46. Saloranta C, Koivisto V, Widen E, Falhot K, De Fronzo RA, Harkonen M, Groop L. Contribution of muscle and liver to glucose-fatty acid cycle in humans. Am J Physiol 1993; 264: E599-E605.
47. Toborek M, Hennig B. Fatty-acid mediated effects on the glutathione redox cycle in cultured endothelial cells. Am J Clin Nutr 1994; 59: 60-65.
48. Paolisso G, Gambardella A, Tagliamonte MR, Saccomanno F, Salvatore T, Gualdiero P, Varricchio M, D'Onofrio F, Howard BV. Does free fatty acid infusion impair insulin action also through an increase in oxidative stress. J Clin Endocrinol Metab 1996; 81: 4244-4248.
49. Paolisso G, Giugliano D. Oxidative stress and insulin action: is there a relationship? Diabetologia 1996; 36: 357-363.
50. Farias RN. Insulin membrane interactions and membrane fluidity changes. Biochem Biophys Acta 1987; 906: 458-468.
51. Borkman M, Storlier LH, Jenkins AB, Chisholm DJ, Campbell LV. The relationship between insulin sensitivity and fatty-acid composition of skeletal muscle phospholipids. N Engl J Med 1993; 328: 238-244.